Income From Continuing Operations - BioNote Inc (KRX:377740) - Alpha Spread
B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 595 KRW 0.33% Market Closed
Market Cap: 468.1B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioNote Inc
Income from Continuing Operations Peer Comparison

Comparables:
068270
302440
H
145020
P
214450
196170

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Income from Continuing Operations
-â‚©20.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Income from Continuing Operations
â‚©320.9B
CAGR 3-Years
-19%
CAGR 5-Years
7%
CAGR 10-Years
10%
SK Bioscience Co Ltd
KRX:302440
Income from Continuing Operations
â‚©22.3B
CAGR 3-Years
-12%
CAGR 5-Years
20%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Income from Continuing Operations
â‚©119B
CAGR 3-Years
27%
CAGR 5-Years
13%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Income from Continuing Operations
â‚©90.8B
CAGR 3-Years
28%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Income from Continuing Operations
-â‚©3.6B
CAGR 3-Years
34%
CAGR 5-Years
17%
CAGR 10-Years
N/A

See Also

What is BioNote Inc's Income from Continuing Operations?
Income from Continuing Operations
-20.5B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Income from Continuing Operations amounts to -20.5B KRW.

Back to Top